.

Guns N' Roses Reunion A Top Tour Of 2017

12-30-2017
.
Guns N' Roses

(hennemusic) U2 and Guns N' Roses have topped live music industry magazine Pollstar's list of worldwide concert tours in 2017. The Guns N' Roses reunion tour with Axl Rose, Slash and Duff McKagan sold 2.68 million tickets over 81 dates for a gross of $292.5 million.

Over the course of 50 shows in 38 cities, the Irish band's 30th anniversary trek for "The Joshua Tree" grossed $316 million with sales of 2.71 million tickets. Coldplay ($238 million) and Bruno Mars ($200.1 million) were third and fourth, respectively, with Metallica rounding out the Top 5 at $152.8 million earned based on sales of 1.56 million tickets.

Other rockers to appear in the Top 20 include Paul McCartney at No. 7 ($132 million), The Rolling Stones at No. 9 ($120 million), Roger Waters at No. 13 ($92.1 million), Bruce Springsteen at No. 14 ($87.8 million) and the Red Hot Chili Peppers at No. 19 ($73.5 million). Read more here.

hennemusic is an official news provider for antiMusic.com.
Copyright hennemusic - Excerpted here with permission.

Guns N' Roses Music, DVDs, Books and more

Guns N' Roses T-shirts and Posters

More Guns N' Roses News

Share this article

Share on Facebook Share on Twitter Share on Google+ Pin it Share on Reddit email this article


Related Stories


Guns N' Roses Icon Optimistic Band Will Have New Music Soon

Guns N' Roses Members Think New Album Is Good Idea

Reunited Guns N' Roses Want To Make New Music Says Slash

Guns N' Roses, Dream Theater Supergroup Sons Of Apollo Cancel Shows

Former Guns N' Roses Guitarist Arrested

Axl Rose Addresses Possible New Guns N' Roses Music

Guns N' Roses Break Metallica Record

Guns N' Roses Stream Acoustic Version Of 'Move To The City'

Guns N' Roses Hit New Milestone With Classic Video

Guns N' Roses' Appetite A Big Hit Again


advertisement




Day In Rock Reports


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2018 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.